Treating severe acute respiratory syndrome

作者: William A. Carter , David Strayer

DOI:

关键词:

摘要: Severe acute respiratory syndrome is treated with a natural human alpha interferon, dsRNA or both interferon and dsRNA.

参考文章(29)
Steven A. Hofstadler, Christian Massire, Stanley T. Crooke, C. Frank Bennett, Brenda F. Baker, Eric E. Swayze, Kristin Sannes Lowery, David J. Ecker, Susan M. Freier, Rangarajan Sampath, Compositions and methods for the treatment of severe acute respiratory syndrome (sars) ,(2004)
Martin C. Woodle, Yijia Liu, Frank Y. Xie, Quinn Q. Tang, Jun Xu, Patrick Y. Lu, Rnai agents for anti-sars coronavirus therapy ,(2004)
William A. Carter, dsRNA-based prevention of viral escape ,(1988)
Michael G Ison, Frederick G Hayden, Therapeutic options for the management of influenza. Current Opinion in Pharmacology. ,vol. 1, pp. 482- 490 ,(2001) , 10.1016/S1471-4892(01)00084-4
Z Zhao, F Zhang, M Xu, K Huang, W Zhong, W Cai, Z Yin, S Huang, Z Deng, M Wei, J Xiong, PM Hawkey, Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China Journal of Medical Microbiology. ,vol. 52, pp. 715- 720 ,(2003) , 10.1099/JMM.0.05320-0